The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties – an alarming global threat of a surge in COVID-19 cases again?
Chiranjib Chakraborty, Manojit Bhattacharya, Hitesh Chopra, Md. Aminul Islam, G. Saikumar, Kuldeep Dhama
Abstract
Chakraborty, Chiranjib PhD; Bhattacharya, Manojit; Chopra, Hitesh PhD; Islam, Md. Aminul; Saikumar, G.; Dhama, Kuldeep MVSc.PhD Author Information
Topics & Concepts
MedicineEvasion (ethics)Immune escapeCoronavirus disease 2019 (COVID-19)Recombinant DNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAntibodyImmune system2019-20 coronavirus outbreakImmunologyGeneticsGeneBiologyOutbreakPathologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches